| 摘要 |
FIELD: medicine. ^ SUBSTANCE: method involves exposing biologically active points electromagnetic radiation using source with radiation line spectrum having luminous body material radiation resonance line. When treating biologically active point of P1 (Zhong-fu), tin-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active point of E 25 (Tian-shu), zinc-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active point of VC 12 (Zhong-wan), bismuth-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active point of F13 (Zhang-men), chrome-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active point of VC 14 (Jui-cue), potassium-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active point of VC 4 (Guan-yuan), lead-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active point of VC 3 (Zhong-ji), mercury-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active point of VB25 (Jing-men), arsenic-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active points of 1 Tian-chi, R 11 (Heng-gu), VC 17 (Tan-zhong), sodium-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active points of VC 5 (Shi-men), VC 17 (Tan-zhong), VC 12 (Zhong-wan), VC 7 (Yin-jiao), calcium-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active points of 1 Tian-chi, R 11 (Heng-gu), VC 17 (Tan-zhong), sodium-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active points of 24 (Ri-yue), 23 (Zhe-jin), osmium-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active points of 1 Tian-chi, R 11 (Heng-gu), VC 17 (Tan-zhong), sodium-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active point of 14 (Ci-men), gold-containing material is selected as the luminous body material of the line spectrum source. ^ EFFECT: enhanced effectiveness in treating biologically active points. |
